SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors
10 references·3 citing·36 second hop
Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors (1996)Relationship between antibody to hepatiti…Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost? (1995)Will human immunodeficiency v…The Retrovirus Epidemiology Donor Study (REDS): rationale and methods (1995)The Retrovirus Epidemiology D…Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests (1995)Post-transfusion hepatitis: i…Infectious Disease Testing for Blood Transfusions (1995)Infectious Disease Testing fo…Human immunodeficiency virus type 1‐infected blood donors: behavioral characteristics and reasons for donation. (1991)Human immunodeficiency virus …Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening (1990)Prevalence of Human Immunodef…TRANSMISSION OF HIV BY BLOOD FROM SERONEGATIVE DONORS (1988)TRANSMISSION OF HIV BY BLOOD …A review of recent events related to surrogate testing of blood to prevent non‐A, non‐B posttransfusion hepatitis (1987)A review of recent events rel…Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood (1986)Antibody to Hepatitis B Core …Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients (1984)Hepatitis B Virus Antibody in…Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at the blood bank of "Hospital Universitário Regional Norte do Paraná", Londrina, PR, Brazil (2003)Evaluation of surrogate marke…[Risk of transfusional-transmitted infections]. (2002)[Risk of transfusional-transm…Riesgo de enfermedades infecciosas transmitidas por transfusión en el Valle del Cauca, Colombia. (1999)Riesgo de enfermedades infecc…Greetings—a final look back with comments about a policy of a zero‐ risk blood supply (1987)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Anti-HBc Testing Can Decrease the Residual Risk of Transfusion-Related HIV Transmission by More Than One Third (1990)Interviews with Anti‐HIV‐Positive Individuals Detected through the Systematic Screening of Blood Donations: Consequences on Predonation Medical Interview (1992)Séropositivité VIH chez les donneurs de sang de 1990 à 1992 : prévalence, estimation du risque résiduel d'infections transfusionnelles et épidémiologie (1993)Calculation of Polychotomous Logistic Regression Parameters Using Individualized Regressions (1984)The Risk of Transfusion-Transmitted Infection (1992)Genomic screening for blood-borne viruses in transfusion settings (2000)Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Emerging Infectious Threats to the Blood Supply (2004)Donor Transaminase and Recipient Hepatitis (1981)Alanine aminotransferase screening of blood donors: Pro (1990)Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population (1991)Donor Deferral Registries (1993)Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)HIV and the blood supply: an analysis of crisis decision making. (1996)Increasing blood availability by changing donation patterns (2003)Improving health profile of blood donors as a consequence of transfusion safety efforts (2007)Cardiovascular and demographic characteristics in whole blood and plasma donors: results from the Donor InSight study (2010)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)Safety of blood donations following a natural disaster (1991)Screening of Selected Male Blood Donors for p24 Antigen of Human Immunodeficiency Virus Type 1 (1990)Dépistage et détection précoce en transfusion sanguine : quand sont-ils indiqués ? (1997)Serologic test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donors (1997)The “safe” blood donor and the national blood supply: is there a new interface? (1998)Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C (1991)Safety of the Blood Supply (1995)Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study (1994)Test-seeking as motivation in volunteer blood donors (2000)Computer-Based Blood Donor Screening: A Status Report (2006)Transfusion-Associated Hepatitis and AIDS (1987)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)The risks of transfusion-transmitted infection: direct estimation and mathematical modelling (2000)Multivariate analysis of determinants of bacterial contamination of whole‐blood donations (2002)Performance of an algorithm for the reentry of volunteer blood donors deferred due to false‐positive test results for antibody to hepatitis B core antigen (2008)
this work references cited by second hop

References

  • 1986Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood328 cited
  • 1984Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients302 cited
  • 1990Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening127 cited
  • 1995Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests91 cited
  • 1995The Retrovirus Epidemiology Donor Study (REDS): rationale and methods89 cited
  • 1995Infectious Disease Testing for Blood Transfusions74 cited
  • 1991Human immunodeficiency virus type 1‐infected blood donors: behavioral characteristics and reasons for donation.54 cited
  • 1987A review of recent events related to surrogate testing of blood to prevent non‐A, non‐B posttransfusion hepatitis44 cited
  • 1988TRANSMISSION OF HIV BY BLOOD FROM SERONEGATIVE DONORS39 cited
  • 1995Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost?36 cited

Cited by

  • 2002[Risk of transfusional-transmitted infections].13 cited
  • 1999Riesgo de enfermedades infecciosas transmitidas por transfusión en el Valle del Cauca, Colombia.12 cited
  • 2003Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at the blood bank of "Hospital Universitário Regional Norte do Paraná", Londrina, PR, Brazil

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

7 cited